tetradecanoylphorbol acetate has been researched along with Aortic Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahrens, I; Aikawa, M; Bassler, N; Bavendiek, U; Bode, C; Ernst, S; Gerdes, N; Libby, P; MacFarlane, L; Maier, C; Missiou, A; Patko, Z; Peter, K; Schönbeck, U; Soosairajah, J; Zirlik, A | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Aortic Diseases
Article | Year |
---|---|
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; CD40 Ligand; Chemotaxis, Leukocyte; CHO Cells; Cholesterol, Dietary; Cricetinae; Cricetulus; Crosses, Genetic; Diet, Atherogenic; Foam Cells; Genetic Predisposition to Disease; Humans; Inflammation; Lipids; Macrophage-1 Antigen; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Monocytes; Peritonitis; Peroxidase; Receptors, LDL; Rheology; Tetradecanoylphorbol Acetate | 2007 |